RT Journal Article
SR Electronic
T1 Methodological Approach for Wastewater Based Epidemiological Studies for SARS-CoV-2
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.02.17.21251905
DO 10.1101/2021.02.17.21251905
A1 Harishankar Kopperi
A1 Athmakuri Tharak
A1 Manupati Hemalatha
A1 Uday Kiran
A1 C. G. Gokulan
A1 Rakesh K Mishra
A1 S Venkata Mohan
YR 2021
UL http://medrxiv.org/content/early/2021/02/22/2021.02.17.21251905.abstract
AB Post COVID-19 outbreak, wastewater-based epidemiology (WBE) studies as surveillance system is becoming an emerging interest due to its functional advantage as tool for early warning signal and to catalyze effective disease management strategies based on the community diagnosis. A comprehensive attempt was made in this study to define a methodological approach for conducting WBE studies in the framework of identifying/selection of surveillance sites, standardizing sampling policy, designing sampling protocols to improve sensitivity, adopting safety protocol, and interpreting the data. The methodology was applied to a community and studied its epidemiological status with reference to occurrence, persistence, and variation of SARS-CoV-2 genome load in wastewater system to understand the prevalence of infection. Hourly and daily grab samples were analyzed and compared with the composite samples over a surveillance window of 7 days. Based on the SARS-CoV-2 RNA copies/L, faeces shedding, and volume of sewage generated the infected individuals and the population who are in active phase in the studied community was estimated.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe work was supported by Council of Scientific and Industrial Research (CSIR) New Delhi India in the form of project entitled Testing for COVID-19 in wastewater as a community surveillance measure (6/1/COVID-19/2020/IMD)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Acquired from CSIR-IICTAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data related to the pre-print is included in the submitted file